Key Findings
In 2018, a large chunk of the market share was held by the North America regional market in the global intraocular lens market when segmented by geography. The market in North America is expected to advance at 4.37% CAGR by the end of the forecasting years.

Market Insights
The prevalence of blindness and vision impairment and other eye-related disorders is expected to increase rapidly among all age group, gender and racial group in North America. However, few factors such as high market saturation, economic slowdown, drying pipelines and increasing competition are some of the factors hampering the potential of the North America ophthalmic drug market. The United States and Canada are considered for the market analysis.

Competitive Insights
Bausch Health Companies Inc. (formerly Valent Pharmaceuticals International Inc.), Staar Surgical Company, Johnson & Johnson, Inc., Lenstec, Inc., Alcon, Eyekon Medical Inc., Pfizer, Santen Pharmaceutical Co., Ltd., HumanOptics AG, Essilor International S.A., Rayner Intraocular Lenses Ltd., Hoya Corporation, Abbott Medical Optics, Inc. (subsidiary of Abbott Laboratories, Inc.), and Carl Zeiss AG are the major market players that are involved in the intraocular lens market.